Classification
This presentation is the property of its rightful owner.
Sponsored Links
1 / 11

Classification PowerPoint PPT Presentation


  • 40 Views
  • Uploaded on
  • Presentation posted in: General

APS, Hereditary Thrombophilias, Unexplained RPL,. Classification. APS, Metaanalysis of 3 RCT (135 patients), (Empson et al, 2002, including :- Cowchock & Reece, 1997; Pattison et al, 2000; Tulppala et al, 1997), RR = 1.05, (CI, 0.66 - 1.68)

Download Presentation

Classification

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Classification

APS,

Hereditary Thrombophilias,

Unexplained RPL,

Classification


Role of aspirin in rpl

APS, Metaanalysis of 3 RCT (135 patients),(Empson et al, 2002, including :- Cowchock & Reece, 1997; Pattison et al, 2000; Tulppala et al, 1997),RR = 1.05, (CI, 0.66 - 1.68)

Unexplained RPL, 3 RCT’s, (Tulppala, et al 1997, Kaandorp, et al 2010, Visser, et al 2011),RR=0.96 (CI, 0.62 -1.46)

Hereditary Thrombophilias, 2 RCT’s, (Kaandorp, et al 2010, Visser, et al 2011),RR=0.68 (CI, 0.33 -1.39)

In RPL, Aspirin has no beneficial effect

Role of Aspirin in RPL


Metaanalysis on heparin lmwh in aps

Kutteh et al, 2.45 (1.11-5.44)

Rai et al, 1.88 (1.15-3.08)

Farquharson et al, 1.18 (0.73-1.91)

Overall, 1.65 (1.2-2.27)

0.1

1

10

Metaanalysis on Heparin & LMWH in APS

  • No measurement of 2GP-1 antibodies

  • No correction for chromosomal aberrations

  • No correction for embryonic structural malformations

  • Overall benefit 22%


Heparins in hereditary thrombophilias

Heparins in Hereditary Thrombophilias

(71.6%)

(50.6%)

(73.3%)

(58.3%)

Clark: Heparin & Aspirin vs surveillance alone, Kaandorp: Nandoparin & Aspirin vs Placebo

Visser: Enoxaparin & placebo vs Aspirin


Anticoagulants in hereditary thrombophilia carp et al 2003

12/17

6/7

8/13

26/37

12/26

7/11

3/12

22/49

Anticoagulants in Hereditary Thrombophilia (Carp et al, 2003)

RR=1.87 (95% CI=1.07-3.28)


Heparins in unexplained rpl

Heparins in Unexplained RPL

  • No beneficial effect


Rcog guideline 2012

RCOG Guideline (2012)


Asrm guideline 2012

ASRM Guideline (2012)


De jong et al 2014

De Jong et al, 2014

  • 9 studies, of 1228 women

  • Assessed enoxaparin or nadroparin or aspirin or a combination of both

  • No beneficial effect found

  • This review does not support the use of anticoagulants in women with unexplained recurrent miscarriage.


Role of aspirin in aps empson et al 2002

Role of Aspirin in APS(Empson et al, 2002)

Aspirin alone did not significantly reduce pregnancy loss,

RR = 1.05, (95% CI, 0.66 - 1.68)


Preconception aspirin

Preconception Aspirin

  • Preconception aspirin was not significantly associated with live birth or pregnancy loss in women with 1 – 2 previous losses.

  • Higher live birth rates in women with a single loss at < 20 weeks during the previous year.

  • Preconception aspirin is not recommended for decrease pregnancy loss or increase live birth rates.


  • Login